An Efficacy and Safety Study of Ezetimibe (MK-0653, SCH 58235) in Addition to Atorvastatin Compared to Placebo in Participants With Primary Hypercholesterolemia (MK-0653-013)
PHASE3CompletedINTERVENTIONAL
Enrollment
628
Participants
Timeline
Start Date
March 6, 2000
Primary Completion Date
July 27, 2001
Study Completion Date
July 27, 2001
Conditions
Hypercholesterolemia
Interventions
DRUG
Placebo
DRUG
Ezetimibe 10 mg
DRUG
Atorvastatin 10 mg
DRUG
Atorvastatin 20 mg
DRUG
Atorvastatin 40 mg
DRUG
Atorvastatin 80 mg
All Listed Sponsors
lead
Organon and Co
INDUSTRY
NCT03867110 - An Efficacy and Safety Study of Ezetimibe (MK-0653, SCH 58235) in Addition to Atorvastatin Compared to Placebo in Participants With Primary Hypercholesterolemia (MK-0653-013) | Biotech Hunter | Biotech Hunter